Expression of functional melanocortin receptors and proopiomelanocortin peptides by human dermal microvascular endothelial cells

Abstract

ABSTRACT: Human dermal microvascular endothelial cells (HDMEC) are capable of mediating leukocyte‐endothelial interactions by the expression of cellular adhesion molecules and the release of proinflammatory cytokines and chemokines during cutaneous inflammation. Recent studies support the important role for proopiomelanocortin (POMC) peptides, such as α‐melanocyte stimulating hormone (α‐MSH), as immunomodulators in the cutaneous immune system. The purpose of the studies described here was to determine whether HDMEC serves as both target and source for POMC peptides. RT‐PCR and Northern blot studies demonstrated the constitutive expression of mRNA for the adrenocorticotropin (ACTH) and α‐MSH‐specific melanocortin receptor 1 (MC‐1R) in HDMEC, and the microvascular endothelial cell line HMEC‐1 that could be upregulated by stimulation with IL‐1β and α‐MSH. HDMEC responded to stimulation by α‐MSH with a dose‐ and time‐dependent synthesis and release of the CXC chemokines, IL‐8 and GROα. Likewise, α‐MSH augmented HDMEC chemokine release induced by TNF or IL‐1. HDMEC were found to constitutively express POMC and prohormone convertase 1 (PC‐1); the latter being required to generate ACTH from the POMC prohormone. POMC and PC‐1 mRNA expression are increased as a result of stimulation with UVB and UVA1 radiation, IL‐1, and α‐MSH. In addition, UV‐radiation is capable of inducing the release of HDMEC, ACTH, and α‐MSH in a time‐ and dose‐dependent fashion. Thus, these data provide evidence that HDMEC are capable of expressing functional MC‐1R, POMC, and PC‐1 mRNA; and of releasing POMC peptides with UV light, IL‐1, and α‐MSH as regulatory factors. The expression and regulation of these peptides may be of importance, not only for the autocrine or paracrine regulation of physiologic functions of dermal endothelial cells, but also for the regulation of certain microvascular‐mediated cutaneous or systemic inflammatory responses.

Key Biomarkers